- Home
- TVTX vs RUN Comparison
TVTX vs RUN Comparison
Compare TVTX & RUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TVTX
- RUN
- Stock Information
- Founded
- TVTX 2008
- RUN 2007
- Country
- TVTX United States
- RUN United States
- Employees
- TVTX N/A
- RUN N/A
- Industry
- TVTX Biotechnology: Pharmaceutical Preparations
- RUN Industrial Machinery/Components
- Sector
- TVTX Health Care
- RUN Miscellaneous
- Exchange
- TVTX Nasdaq
- RUN Nasdaq
- Market Cap
- TVTX 1.7B
- RUN N/A
- IPO Year
- TVTX N/A
- RUN 2015
- Fundamental
- Price
- TVTX $20.44
- RUN $8.50
- Analyst Decision
- TVTX Strong Buy
- RUN Buy
- Analyst Count
- TVTX 14
- RUN 21
- Target Price
- TVTX $33.31
- RUN $16.21
- AVG Volume (30 Days)
- TVTX 1.6M
- RUN 10.4M
- Earning Date
- TVTX 05-01-2025
- RUN 05-07-2025
- Dividend Yield
- TVTX N/A
- RUN N/A
- EPS Growth
- TVTX N/A
- RUN N/A
- EPS
- TVTX N/A
- RUN N/A
- Revenue
- TVTX $273,533,000.00
- RUN $2,083,802,000.00
- Revenue This Year
- TVTX $68.31
- RUN $8.45
- Revenue Next Year
- TVTX $55.65
- RUN $12.85
- P/E Ratio
- TVTX N/A
- RUN N/A
- Revenue Growth
- TVTX 75.65
- RUN N/A
- 52 Week Low
- TVTX $6.01
- RUN $5.45
- 52 Week High
- TVTX $25.29
- RUN $22.26
- Technical
- Relative Strength Index (RSI)
- TVTX 61.49
- RUN 66.01
- Support Level
- TVTX $19.84
- RUN $6.88
- Resistance Level
- TVTX $22.07
- RUN $7.51
- Average True Range (ATR)
- TVTX 1.11
- RUN 0.49
- MACD
- TVTX 0.42
- RUN 0.12
- Stochastic Oscillator
- TVTX 77.85
- RUN 91.65
About TVTX Travere Therapeutics Inc.
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.